Longevity Biotech, Inc.
CAGE Code: 615P4
NCAGE Code: 615P4
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 962502287
Summary
Longevity Biotech, Inc. is an Active Commercial Supplier with the Cage Code 615P4 and is tracked by Dun & Bradstreet under DUNS Number 962502287..
Address
4619 Woodland Ave
Philadelphia PA 19143-3862
United States
Points of Contact
No Points of Contact...
Related Information
People who viewed this 'CAGE Code' also viewed...
Faith Assembly Of God Of Frankford Dalonzo-Lancaster Inc Central National-Gottesman Warren Intl Inc Howard Refrigerator Co Inc Silver Lake Foods Inc Industrial Oil Services Inc Center For Applied Research, Inc Boyer Earl G Jr Stelwagon Mfg Co Angelo Colonno Ge Energy Rentals General Electric Co Housewares And General Electric Co Appliance And Alex Products Guilbert Inc Key Chemicals Inc American Transformer Co Auto Engineering And Machine Co Neo-Quest Chemical Co
Frequently Asked Questions (FAQ) for CAGE 615P4
- What is CAGE Code 615P4?
- 615P4 is the unique identifier used by NATO Organizations to reference the physical entity known as Longevity Biotech, Inc. located at 4619 Woodland Ave, Philadelphia PA 19143-3862, United States.
- Who is CAGE Code 615P4?
- 615P4 refers to Longevity Biotech, Inc. located at 4619 Woodland Ave, Philadelphia PA 19143-3862, United States.
- Where is CAGE Code 615P4 Located?
- CAGE Code 615P4 is located in Philadelphia, PA, USA.
Contracting History for CAGE 615P4 Most Recent 25 Records
- HHSN268201700022C
- Igf::Ot::Igf Sbir Topic 099, Phase I, Inhalation 5A Apolipoprotein A-I Mimetic Peptide For The Treatment Of Asthma (Sbir-Tt)
- 29 May 2019
- Igf::Ot::Igf Sbir Topic 099, Phase I, Inhalation 5A Apolipoprotein A-I Mimetic Peptide For The Treatment Of Asthma (Sbir-Tt)
- National Institutes Of Health Nhlbi
- Department Of Health And Human Services (Hhs)
- $348,123.00
- Department Of Health And Human Services (Hhs)
- HHSN268201700022C
- Igf::Ot::Igf Sbir Topic 099, Phase I, Inhalation 5A Apolipoprotein A-I Mimetic Peptide For The Treatment Of Asthma (Sbir-Tt)
- 29 Mar 2019
- Igf::Ot::Igf Sbir Topic 099, Phase I, Inhalation 5A Apolipoprotein A-I Mimetic Peptide For The Treatment Of Asthma (Sbir-Tt)
- National Institutes Of Health Nhlbi
- Department Of Health And Human Services (Hhs)
- $348,123.00
- Department Of Health And Human Services (Hhs)
- HHSN268201700022C
- Igf::Ot::Igf Sbir Topic 099, Phase I, Inhalation 5A Apolipoprotein A-I Mimetic Peptide For The Treatment Of Asthma (Sbir-Tt)
- 13 Aug 2018
- Igf::Ot::Igf Sbir Topic 099, Phase I, Inhalation 5A Apolipoprotein A-I Mimetic Peptide For The Treatment Of Asthma (Sbir-Tt)
- National Institutes Of Health Nhlbi
- Department Of Health And Human Services (Hhs)
- $348,123.00
- Department Of Health And Human Services (Hhs)
- HHSN268201700022C
- Igf::Ot::Igf Sbir Topic 099, Phase I, Inhalation 5A Apolipoprotein A-I Mimetic Peptide For The Treatment Of Asthma (Sbir-Tt)
- 30 Oct 2018
- Igf::Ot::Igf Sbir Topic 099, Phase I, Inhalation 5A Apolipoprotein A-I Mimetic Peptide For The Treatment Of Asthma (Sbir-Tt)
- National Institutes Of Health Nhlbi
- Department Of Health And Human Services (Hhs)
- $348,123.00
- Department Of Health And Human Services (Hhs)
- HHSN268201700022C
- Igf::Ot::Igf
- 28 Sep 2017
- Igf::Ot::Igf
- National Institutes Of Health Nhlbi
- Department Of Health And Human Services (Hhs)
- $348,123.00
- Department Of Health And Human Services (Hhs)
- HHSN268201700022C
- Igf::Ot::Igf
- 27 Nov 2017
- Igf::Ot::Igf
- National Institutes Of Health Nhlbi
- Department Of Health And Human Services (Hhs)
- $348,123.00
- Department Of Health And Human Services (Hhs)